Michael Bolick, Lab21
The Life Sciences Cluster draws on the region’s strengths in medical, marine, agricultural and environmental sciences, and includes entities involved in processes that require biological inputs. Examples include those focused on biopharmaceuticals, biological products, gene and protein therapy, tissue engineering, genetically modified crops, medical devices and pharmaceutical manufacturing.
Formerly the Palmetto Biotechnology Alliance (PBA), SC BIO is an association of individuals and organizations dedicated to growing the life science industry in South Carolina. SC BIO works on behalf of its members to expand the infrastructure, legislative, and funding requirements that help life science companies thrive. SC BIO also offers its members valuable networking opportunities that allow key players from the business, research, investment, government, and support service sectors to establish relationships. These connections help move ideas from patent to production, and take companies from start-up to success.
A confluence of medical, marine, agricultural and environmental sciences provides a rich environment for research and discovery. Greater Charleston is home to numerous bioscience and technology companies involved in everything from research & development to manufacturing.
Learn more about Biosciences from partners at the Charleston Regional Development Alliance
New Carolina Life Sciences Cluster Champion Michael Bolick of Lab21 on SC Business Reveiw
Lab21 is the market leader in the UK for companion diagnostic testing. A companion diagnostic is a test that is given as a “companion” to a drug therapy to help doctors provide the right drug at the right dose and right time to the right patient. In South Carolina, there is strong support from leading local clinicians and each of the major regional hospitals to change the local landscape in the battle against cancer and infectious disease. Larry Gluck. medical director for the Greenville Hospital System’s Cancer Center, is helping spread the word on how Lab21’s local presence can help accelerate local options for diagnosis and treatment of cancer. Learn more: http://www.sclaunch.org/client_videos.shtml and then click on the Lab21 logo.
Lab21 sells standalone diagnostic test kits into 120 countries worldwide. At the end of August, Lab21 announced its first global exclusive license to develop diagnostic tools around a particular genetic mutation. Added excitement is that this license is with a South Carolina entity, and Labe 21 now has compelling technology development relationships with all three of South Carolina’s leading research universities.
Read more about Lab21 in Katherine Meyer's story published in Business Black Box in February 2010: Business of BioTech: Uniting an Industry to Fuel South Carolina's Economy
Subscribe to our E-Newsletter and stay connected with New Carolina.
Thank you for signing up! Look for our monthly newsletter in your inbox soon.